Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • DoP earmarks Rs 300...

    DoP earmarks Rs 300 crore for common facilities in medical parks

    Written by savita thakur thakur Published On 2016-08-22T12:42:58+05:30  |  Updated On 22 Aug 2016 12:42 PM IST
    DoP earmarks Rs 300 crore for common facilities in medical parks

    New Delhi : Department of Pharmaceuticals (DoP) has come up with a scheme to finance common facility centres like component and radiation testing in proposed medical device parks with an outlay of Rs 300 crore as it looks to curb import dependence.


    "The Department has formulated a scheme for financing common facility centres in medical device park with an outlay of Rs 300 crore," DoP said in a statement.


    Development of common facilitation centre for medical devices (DCFC-MD) scheme proposes to give Rs 25 crore or 70 per cent of cost of equipment and machinery and fixed assets as grant-in-aid for setting up of common facility centres like moduling centres, it added.


    "The scheme also proposes to cater to all segments of medical device industry like electrical and electronic, biomaterial and implants, etc," it said.


    The scheme also aims to offer similar benefits to medical devices park to be proposed by various state governments.


    The plan has been appraised by standing finance committee (SFC) on July 26, and is being put up for approval of the Chemicals and Fertilisers Minister.


    "It will be revised once approved by the Minister," the statement said.


    To reduce import dependence, the government has decided to establish six bulk drug and medical devices parks, which will entail a combined investment of Rs 60,000 crore.


    As per various estimates, once these parks become operational, they can bring down the cost of production of devices and bulk drugs by at least 30 per cent and in long-run, this will help the general public.


    These parks will be established on the public private partnership (PPP) mode and the centre is in talks with various states for setting up of these parks.


    The parks will have common facilities like testing, power and effluent treatment plants.

    Bulk drugcommon facilitiescommon facilities in medical parksDCFC-MDDepartment of PharmaceuticalsDOPInvestmentmedical devicemedical parks in indiaPPPpublic private partnershipSFCstanding finance committee
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok